But EyePoint appears to have reversed its fortunes thanks to positive new interim data on its lead asset in diabetic macular edema (DME). In the midstage VERONA trial, Duravyu delivered “early ...

Doctors treat diabetic macular edema (DME) in two ways. First, they tackle what's causing it, like high blood sugar or high blood pressure. Just keeping your levels close to normal can stop eye ...

DME is a disease driven by anti-vascular endothelial growth factor (VEGF) and inflammatory mechanisms. Historically, 50% of DME patients do not respond completely to anti-VEGF therapies due to other ...

One of the leading alternative energy sources is Dimethyl ether (DME). DME is a synthetically produced, clean burning, non-toxic, renewable alternative to diesel for use in specially designed ...